Be4ward

Traceability and Serialisation

Pharmaceutical product serialisation legislation is being developed and approved across the world to ensure patient safety and prevent fraud. Meeting the legislation across the supply chain is a complex and very costly undertaking. Failure to comply with these legislative requirements will mean that pharmaceutical companies will not be able to sell products in the affected markets.

Traceability and serialisation legislation requires product packs and, depending on the legislation, shippers to be uniquely identified with serial numbers. Information about the product, its serialisation, its status and in some cases its movement in the supply chain are then exchanged between supply chain participants and/or authorities.

Whilst some pharmaceutical companies understand this legislation and have a clear strategy and programme of capability implementation under way, others do not.

Having successfully dealt with legislative drivers, many companies are now realising the secondary benefits serialisation has brought to their supply chain.